William Blair

Selected news for the capital firm - William Blair, collected since 10/2017. Recent stories appear in watchlistnews.com and zolmax.com. This capital firm shares healthcare news with Medical Research, CRISPR, Henry Schein, Fitbit, Amedisys and hundreds of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
7/20/2021 Praxis Precision Medicines (NASDAQ:PRAX) Cut to “Sell” at Zacks Investment Research - Transcript Daily transcriptdaily.com ... company translating genetic insights into the development of therapies for central nervous system disorders characterized by neuronal imbalance. Praxis Precision Medicines Inc. is based in CAMBRIDGE, Mass. “Get Praxis Precision Medicines alerts: Separately, William Blair began coverage on Praxis Precision Medicines in a research note on Monday, May 3rd. They set an outperform rating on the stock. One investment analyst has rated the stock with a sell rating and ...
7/20/2021 Zacks Investment Research Upgrades Ikena Oncology (NASDAQ:IKNA) to Hold - Ticker Report Ticker Report ... Äù rating for the company. Credit Suisse Group began coverage on Ikena Oncology in a report on Tuesday, April 20th. They set an ‚Äúoutperform‚Äù rating and a $30.00 price objective for the company. William Blair began coverage on Ikena Oncology in a research report on Tuesday, April 20th. They set an ‚Äúoutperform‚Äù rating for the company. Finally, Cowen reaffirmed a ‚Äúbuy‚Äù rating on shares of Ikena Oncology ...
7/20/2021 Cadence Bancorporation (CADE) to Release Quarterly Earnings on Thursday | Daily Political Daily Political ... on Monday, June 14th. Royal Bank of Canada cut their price target on Biogen from $400.00 to $354.00 and set a sector perform rating on the stock in a report on Monday, June 28th. William Blair raised shares of Biogen from a market perform rating to an outperform rating in a research report on Tuesday, June 8th. Barclays raised their target price on Biogen from $265.00 to $395.00 and gave ...
7/20/2021 Morgan Stanley Lowers Biogen (NASDAQ:BIIB) Price Target to $453.00 - Ticker Report Ticker Report ... report report published on Friday morning, Analyst Ratings Network reports. They currently have an overweight rating on the biotechnology company’s stock.Other equities analysts have also recently issued research reports about the stock. William Blair raised shares of Biogen from a market perform rating to an outperform rating in a research note on Tuesday, June 8th. Jefferies Financial Group increased their target price on Biogen from $450.00 to $500.00 ...
7/20/2021 Critical Comparison: PowerFleet (NASDAQ:PWFL) versus ALR Technologies (OTCMKTS:ALRT) | Daily Political Daily Political ... chronically ill and frail, through its Medicare Advantage plans. Alignment Healthcare Inc. is based in ORANGE, Calif. “ Get Alignment Healthcare alerts:A number of other equities analysts also recently commented on the stock. William Blair initiated coverage on shares of Alignment Healthcare in a research note on Tuesday, April 20th. They issued an outperform rating on the stock. The Goldman Sachs Group began coverage on shares of Alignment Healthcare ...
7/19/2021 Analysts Offer Insights on Healthcare Companies: Biogen (NASDAQ: BIIB) and Icon (NASDAQ: ICLR) analystratings.com ... such as Phathom Pharmaceuticals, Mirati Therapeutics, and CureVac. Biogen has an analyst consensus of Moderate Buy, with a price target consensus of $429.64, representing a 32.6% upside. In a report issued on July 2, William Blair also reiterated a Buy rating on the stock. See today’s analyst top recommended stocks Icon (ICLR) In a report issued on July 16, Elizabeth Anderson CFA from Evercore ISI maintained a Buy rating ...
7/12/2021 Public Employees Retirement System of Ohio Increases Position in Merit Medical Systems, Inc. (NASDAQ:MMSI) thelincolnianonline.com ... Merit Medical Systems by 2.8% in the 1st quarter. BlackRock Inc. now owns 7,822,133 shares of the medical instruments supplier’s stock worth $468,389,000 after acquiring an additional 212,022 shares in the last quarter. William Blair Investment Management LLC increased its holdings in Merit Medical Systems by 2.6% in the 1st quarter. William Blair Investment Management LLC now owns 3,476,929 shares of the medical instruments supplier’s stock worth $208,199,000 ...
7/5/2021 Brokerages Set Krystal Biotech, Inc. (NASDAQ:KRYS) PT at $103.75 - The Cerbat Gem thecerbatgem.com ... year is $103.75.Several research firms have issued reports on KRYS. Jonestrading reiterated a “buy” rating and issued a $97.00 price objective on shares of Krystal Biotech in a research report on Friday. William Blair reiterated a “buy” rating on shares of Krystal Biotech in a research report on Friday. Finally, Zacks Investment Research cut Krystal Biotech from a “hold” rating to a “sell” rating in ...
7/5/2021 Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Lazard Asset Management LLC Dakota Financial News ... LLC’s holdings in Charles River Laboratories International were worth $38,059,000 as of its most recent SEC filing. A number of other hedge funds also recently added to or reduced their stakes in CRL. William Blair Investment Management LLC raised its holdings in Charles River Laboratories International by 657.7% during the first quarter. William Blair Investment Management LLC now owns 992,180 shares of the medical research company’s stock worth ...
6/30/2021 Abiomed, Inc. (NASDAQ:ABMD) Shares Sold by Amalgamated Bank - Mayfield Recorder Mayfield Recorder ... Abiomed by 13.2% in the first quarter. Baillie Gifford & Co. now owns 3,442,328 shares of the medical equipment provider’s stock valued at $1,097,173,000 after purchasing an additional 400,501 shares in the last quarter. William Blair Investment Management LLC boosted its holdings in Abiomed by 65.4% in the first quarter. William Blair Investment Management LLC now owns 937,156 shares of the medical equipment provider’s stock valued at $298,700,000 after ...
6/23/2021 Oppenheimer Raises Nutanix (NASDAQ:NTNX) Price Target to $44.00 - American Banking News American Banking News ... on Thursday, February 25th. Royal Bank of Canada raised their price objective on shares of Nutanix from $45.00 to $50.00 and gave the stock an “outperform” rating in a research report on Wednesday. William Blair restated an “outperform” rating on shares of Nutanix in a research report on Thursday, May 27th. Morgan Stanley raised their price objective on shares of Nutanix from $30.00 to $35.00 and gave the ...
6/23/2021 Royal Bank of Canada Increases Nutanix (NASDAQ:NTNX) Price Target to $50.00 - American Banking News American Banking News ... Nutanix in a report on Tuesday, February 23rd. KeyCorp upped their price target on Nutanix from $37.00 to $42.00 and gave the company an “overweight” rating in a report on Thursday, February 25th. William Blair reaffirmed an “outperform” rating on shares of Nutanix in a report on Thursday, May 27th. Wells Fargo & Company upped their price target on Nutanix from $35.00 to $40.00 in a report on Thursday ...
6/23/2021 Needham & Company LLC Raises Nutanix (NASDAQ:NTNX) Price Target to $61.00 - American Banking News American Banking News ... stock an “overweight” rating in a report on Thursday, May 27th. Wells Fargo & Company raised their price objective on shares of Nutanix from $35.00 to $40.00 in a report on Thursday, February 25th. William Blair reaffirmed an “outperform” rating on shares of Nutanix in a report on Thursday, May 27th. Oppenheimer raised their price objective on shares of Nutanix from $40.00 to $44.00 and gave the stock an ...
6/22/2021 Korea Investment CORP Sells 5,600 Shares of Veeva Systems Inc. (NYSE:VEEV) - Watch List News watchlistnews.com ... Systems by 1.0% during the 1st quarter. Champlain Investment Partners LLC now owns 721,697 shares of the technology company’s stock valued at $188,536,000 after purchasing an additional 6,885 shares during the last quarter. William Blair Investment Management LLC lifted its holdings in Veeva Systems by 1.1% during the 1st quarter. William Blair Investment Management LLC now owns 82,226 shares of the technology company’s stock valued at $21,481,000 after ...
6/22/2021 Abiomed, Inc. (NASDAQ:ABMD) Shares Acquired by Banco Bilbao Vizcaya Argentaria S.A. - Dakota Financial News Dakota Financial News ... of Abiomed by 13.2% during the first quarter. Baillie Gifford & Co. now owns 3,442,328 shares of the medical equipment provider’s stock worth $1,097,173,000 after purchasing an additional 400,501 shares in the last quarter. William Blair Investment Management LLC grew its stake in shares of Abiomed by 65.4% during the first quarter. William Blair Investment Management LLC now owns 937,156 shares of the medical equipment provider’s stock worth $298,700,000 ...
6/22/2021 Abiomed, Inc. (NASDAQ:ABMD) Stake Boosted by Bank of New York Mellon Corp - Transcript Daily transcriptdaily.com ... in Abiomed by 13.2% during the first quarter. Baillie Gifford & Co. now owns 3,442,328 shares of the medical equipment provider’s stock worth $1,097,173,000 after purchasing an additional 400,501 shares during the last quarter. William Blair Investment Management LLC lifted its stake in Abiomed by 65.4% in the first quarter. William Blair Investment Management LLC now owns 937,156 shares of the medical equipment provider’s stock valued at $298,700,000 after ...
6/22/2021 Aviva PLC Has $5.95 Million Holdings in Abiomed, Inc. (NASDAQ:ABMD) American Banking News ... in Abiomed by 13.2% during the first quarter. Baillie Gifford & Co. now owns 3,442,328 shares of the medical equipment provider’s stock worth $1,097,173,000 after buying an additional 400,501 shares in the last quarter. William Blair Investment Management LLC grew its holdings in Abiomed by 65.4% during the first quarter. William Blair Investment Management LLC now owns 937,156 shares of the medical equipment provider’s stock worth $298,700,000 after buying ...
6/22/2021 Aviva PLC Has $5.95 Million Holdings in Abiomed, Inc. (NASDAQ:ABMD) - Ticker Report Ticker Report ... in Abiomed by 13.2% during the first quarter. Baillie Gifford & Co. now owns 3,442,328 shares of the medical equipment provider’s stock worth $1,097,173,000 after buying an additional 400,501 shares in the last quarter. William Blair Investment Management LLC grew its holdings in Abiomed by 65.4% during the first quarter. William Blair Investment Management LLC now owns 937,156 shares of the medical equipment provider’s stock worth $298,700,000 after buying ...
6/22/2021 Nutanix (NASDAQ:NTNX) Sets New 52-Week High at $39.41 - American Banking News American Banking News ... 38.00 and gave the company an “overweight” report on Thursday, May 27th. Wells Fargo & Company upped their price target on Nutanix from $35.00 to $40.00 in a research report on Thursday, February 25th. William Blair restated an “outperform” rating on shares of Nutanix in a research report on Thursday, May 27th. Finally, Morgan Stanley upped their price target on Nutanix from $30.00 to $35.00 and gave the company ...
6/21/2021 Analysts Set ImmunoGen, Inc. (NASDAQ:IMGN) Target Price at $10.00 zolmax.com ... to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $10.00.Several equities research analysts have commented on IMGN shares. William Blair reiterated an “outperform” rating on shares of ImmunoGen in a research note on Monday, May 10th. TheStreet lowered shares of ImmunoGen from a “c” rating to a “d+” rating in a ...